NCT04798690View on ClinicalTrials.gov

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

RecruitingOBSERVATIONAL

Enrollment

2,500

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions

Growth Hormone DeficiencyIdiopathic Short StatureTurner SyndromeSmall for Gestational Age

Trial Locations (1)

03722

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY